{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:38:01Z","timestamp":1770417481582,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical Science and Technology Research Project of Henan province","award":["201702063"],"award-info":[{"award-number":["201702063"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.lfs.2019.02.059","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T11:52:52Z","timestamp":1552305172000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart"],"prefix":"10.1016","volume":"224","author":[{"given":"Cui","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.02.059_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/5584_2017_105","article-title":"Pathogenesis, clinical features and treatment of diabetic cardiomyopathy","volume":"1067","author":"Alonso","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2019.02.059_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2019.02.059_bb0015","doi-asserted-by":"crossref","unstructured":"Kawaguchi, M., Techigawara, M., Ishihata, T., Asakura, T., Saito, F., Maehara, K. Maruyama, Y., A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension, Heart Vessel.. 12(6)(1997) 267\u201374.","DOI":"10.1007\/BF02766802"},{"issue":"9","key":"10.1016\/j.lfs.2019.02.059_bb0020","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1006\/jmcc.2000.1197","article-title":"Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors","volume":"32","author":"Chen","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.lfs.2019.02.059_bb0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/dmrr.322","article-title":"Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium","volume":"18","author":"Hileeto","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.lfs.2019.02.059_bb0030","doi-asserted-by":"crossref","unstructured":"Zeisberg, E.M., Tarnavski, O., Zeisberg, M., Dorfman, A.L., McMullen, J.R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W.T., Roberts, A.B., Neilson, E.G., Sayegh, M.H., Izumo, S. Kalluri, R., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat. Med.. 13(8)(2007) 952\u201361.","DOI":"10.1038\/nm1613"},{"issue":"2","key":"10.1016\/j.lfs.2019.02.059_bb0035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jcmm.13360","article-title":"Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy","volume":"22","author":"Liu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2019.02.059_bb0040","doi-asserted-by":"crossref","unstructured":"Feng, B., Cao, Y., Chen, S., Chu, X., Chu, Y. Chakrabarti, S., miR-200b mediates endothelial-to-mesenchymal transition in diabetic cardiomyopathy, Diabetes. 65(3)(2016) 768\u201379.","DOI":"10.2337\/db15-1033"},{"key":"10.1016\/j.lfs.2019.02.059_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","article-title":"Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy","volume":"133","author":"Yue","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2019.02.059_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yjmcc.2015.12.016","article-title":"Transcriptional control of cardiac fibroblast plasticity","volume":"91","author":"Lighthouse","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2019.02.059_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/path.4814","article-title":"Fine-tuning vascular fate during endothelial-mesenchymal transition","volume":"241","author":"Xiao","year":"2017","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.lfs.2019.02.059_bb0060","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2019.02.059_bb0065","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbrc.2017.07.108","article-title":"MicroRNA-193-5p modulates angiogenesis through IGF2 in type 2 diabetic cardiomyopathy","volume":"491","author":"Yi","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2019.02.059_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3892\/br.2017.841","article-title":"Role of microRNAs in the pathogenesis of diabetic cardiomyopathy","volume":"6","author":"Liu","year":"2017","journal-title":"Biomed Rep"},{"issue":"1","key":"10.1016\/j.lfs.2019.02.059_bb0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2008.08.107","article-title":"MIR-451 and Imatinib mesylate inhibit tumor growth of glioblastoma stem cells","volume":"376","author":"Gal","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.02.059_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918783132","article-title":"HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9","volume":"10","author":"Chen","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.lfs.2019.02.059_bb0085","unstructured":"Liu, K., Tian, H., Zhang, Y., Zhao, H. Ma, K., miR-451 selectively increases sensitivity to cisplatin in ERCC1-high non-small cell lung cancer cells, J. Cell. Biochem.. 2018)."},{"key":"10.1016\/j.lfs.2019.02.059_bb0090","doi-asserted-by":"crossref","unstructured":"Sun Y, P.R., Peng H, Liu H, Wen L, Wu T, Yi H, Li A, Zhang Z, miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy, Mol. Cell. Endocrinol.. 433 2016) 75\u201386.","DOI":"10.1016\/j.mce.2016.06.004"},{"issue":"11","key":"10.1016\/j.lfs.2019.02.059_bb0095","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/jcmm.12380","article-title":"MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1","volume":"18","author":"Song","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.02.059_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.02.059_bb0105","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.bbadis.2018.02.012","article-title":"TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy","volume":"1864","author":"Xiao","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"issue":"22","key":"10.1016\/j.lfs.2019.02.059_bb0110","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1042\/CS20160074","article-title":"OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells","volume":"130","author":"Wu","year":"2016","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.lfs.2019.02.059_bb0115","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1002\/jcb.26041","article-title":"Cucurbitacin B protects against pressure overload induced cardiac hypertrophy","volume":"118","author":"Xiao","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.lfs.2019.02.059_bb0120","doi-asserted-by":"crossref","first-page":"H1143","DOI":"10.1152\/ajpheart.00601.2014","article-title":"Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-alpha\/ASK1\/JNK pathway","volume":"308","author":"Wu","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2019.02.059_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11010-017-2956-6","article-title":"Evodiamine attenuates TGF-beta1-induced fibroblast activation and endothelial to mesenchymal transition","volume":"430","author":"Wu","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2019.02.059_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12933-018-0684-1","article-title":"Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides","volume":"17","author":"Ghosh","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2019.02.059_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1278436","article-title":"MicroRNA as a therapeutic target in cardiac remodeling","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2019.02.059_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-016-2716-z","article-title":"Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy","volume":"417","author":"Zhang","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2019.02.059_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11427-017-9197-5","article-title":"AMPK and cardiac remodelling","volume":"61","author":"Feng","year":"2018","journal-title":"Sci. China Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2019.02.059_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCRESAHA.109.201590","article-title":"Activation and signaling by the AMP-activated protein kinase in endothelial cells","volume":"105","author":"Fisslthaler","year":"2009","journal-title":"Circ. Res."},{"issue":"60","key":"10.1016\/j.lfs.2019.02.059_bb0155","doi-asserted-by":"crossref","first-page":"101784","DOI":"10.18632\/oncotarget.21695","article-title":"Metformin prevents peritendinous fibrosis by inhibiting transforming growth factor-beta signaling","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2019.02.059_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.abb.2018.01.006","article-title":"Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK\/TGF-beta\/Smads signaling pathway","volume":"640","author":"Xiao","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.lfs.2019.02.059_bb0165","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.celrep.2016.11.066","article-title":"Integrative analysis of PRKAG2 cardiomyopathy iPS and microtissue models identifies AMPK as a regulator of metabolism, survival, and fibrosis","volume":"17","author":"Hinson","year":"2016","journal-title":"Cell Rep."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519301493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519301493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:18:36Z","timestamp":1758399516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519301493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"alternative-id":["S0024320519301493"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.02.059","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.02.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}